CAPTRUST Financial Advisors’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
Other funds holding APGE
CAPTRUST Financial Advisors's APGE Position: Q3 2026 in Review
CAPTRUST Financial Advisors sold out of Apogee Therapeutics (APGE) in Q3 2026, closing a stake of 3,241 shares — an estimated $430K sold.
CAPTRUST Financial Advisors first reported a position in APGE in Q2 2026 and held it in 1 quarter. The position peaked at $430K in Q2 2026. 2 funds tracked by Wall St. Rank hold APGE as of Q3 2026.
- CAPTRUST Financial Advisors reported no remaining Apogee Therapeutics position as of Q3 2026 after selling out during the quarter.
- CAPTRUST Financial Advisors sold 3,241 Apogee Therapeutics shares in Q3 2026, an estimated $430K.
- CAPTRUST Financial Advisors first reported a position in Apogee Therapeutics in Q2 2026 and held it in 1 quarter.
- CAPTRUST Financial Advisors's Apogee Therapeutics position peaked at $430K in Q2 2026.
- 2 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q3 2026.
Based on CAPTRUST Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.